Innoviva Accounts Payable vs Treasury Stock Analysis

INVA Stock

USD 15.26 0.27 1.80%

Innoviva financial indicator trend analysis is infinitely more than just investigating Innoviva recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Innoviva is a good investment. Please check the relationship between Innoviva Accounts Payable and its Treasury Stock accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Innoviva. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.

For information on how to trade Innoviva Stock refer to our How to Trade Innoviva Stock guide.

Accounts Payable vs Treasury Stock

Accounts Payable vs Treasury Stock Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Innoviva Accounts Payable account and Treasury Stock. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Innoviva's Accounts Payable and Treasury Stock is 0.56. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Treasury Stock in the same time period over historical financial statements of Innoviva, assuming nothing else is changed. The correlation between historical values of Innoviva's Accounts Payable and Treasury Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Innoviva are associated (or correlated) with its Treasury Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Treasury Stock has no effect on the direction of Accounts Payable i.e., Innoviva's Accounts Payable and Treasury Stock go up and down completely randomly.

Correlation Coefficient

0.56

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Accounts Payable

An accounting item on the balance sheet that represents Innoviva obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Innoviva are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Treasury Stock

Most indicators from Innoviva's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Innoviva current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Innoviva. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.

For information on how to trade Innoviva Stock refer to our How to Trade Innoviva Stock guide.At present, Innoviva's Selling General Administrative is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value Over EBITDA is expected to grow to 5.86, whereas Discontinued Operations is forecasted to decline to (89.7 M).

Innoviva fundamental ratios Correlations

	Total Assets	Total Stockholder Equity	Retained Earnings	Other Assets	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Other Liab	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Short Term Investments	Non Current Liabilities Total	Other Current Assets	Property Plant And Equipment Gross
Total Assets		0.84	0.71	0.39	-0.39	-0.19	0.18	0.12	-0.15	0.03	0.34	-0.36	-0.05	-0.12	0.29	0.68	0.97	-0.18	0.09	0.27	0.68	-0.05	0.86	0.02	0.37	-0.36
Total Stockholder Equity	0.84		0.86	0.46	-0.59	-0.37	-0.37	-0.41	0.0	0.23	0.34	0.08	0.12	-0.62	0.42	0.58	0.78	-0.57	-0.44	0.33	0.51	-0.38	0.81	-0.45	0.33	0.08
Retained Earnings	0.71	0.86		0.46	-0.82	-0.77	-0.36	-0.37	-0.22	0.08	0.44	0.2	0.0	-0.54	0.26	0.47	0.72	-0.44	-0.42	-0.06	0.49	-0.71	0.64	-0.22	0.24	0.2
Other Assets	0.39	0.46	0.46		0.04	-0.33	-0.21	-0.09	-0.27	-0.49	-0.09	-0.3	-0.3	-0.27	-0.48	0.49	0.43	-0.24	-0.09	-0.21	0.74	-0.22	0.33	-0.15	0.82	-0.3
Common Stock Shares Outstanding	-0.39	-0.59	-0.82	0.04		0.79	0.38	0.44	0.13	-0.42	-0.46	-0.6	-0.2	0.49	-0.49	-0.15	-0.39	0.39	0.5	0.04	0.05	0.82	-0.39	0.16	0.3	-0.6
Other Stockholder Equity	-0.19	-0.37	-0.77	-0.33	0.79		0.33	0.28	0.39	0.04	-0.32	-0.4	0.11	0.35	0.08	-0.19	-0.26	0.2	0.34	0.43	-0.18	0.92	-0.14	-0.04	-0.04	-0.4
Total Liab	0.18	-0.37	-0.36	-0.21	0.38	0.33		0.97	-0.3	-0.28	-0.03	-0.72	-0.28	0.92	-0.24	0.14	0.23	0.76	0.97	-0.1	0.18	0.6	-0.03	0.87	-0.03	-0.72
Short Long Term Debt Total	0.12	-0.41	-0.37	-0.09	0.44	0.28	0.97		-0.41	-0.41	-0.19	-0.75	-0.42	0.94	-0.44	0.19	0.18	0.81	0.99	-0.18	0.22	0.56	-0.13	0.91	0.07	-0.75
Other Current Liab	-0.15	0.0	-0.22	-0.27	0.13	0.39	-0.3	-0.41		0.42	-0.15	0.26	0.27	-0.26	0.51	-0.42	-0.2	-0.29	-0.32	0.31	-0.27	0.23	0.06	-0.42	-0.24	0.26
Total Current Liabilities	0.03	0.23	0.08	-0.49	-0.42	0.04	-0.28	-0.41	0.42		0.3	0.68	0.55	-0.38	0.79	-0.1	-0.11	-0.47	-0.44	0.6	-0.56	-0.2	0.24	-0.35	-0.58	0.68
Other Liab	0.34	0.34	0.44	-0.09	-0.46	-0.32	-0.03	-0.19	-0.15	0.3		0.15	0.49	-0.23	0.45	0.09	0.34	-0.42	-0.23	0.06	0.09	-0.33	0.55	-0.15	-0.03	0.15
Property Plant And Equipment Net	-0.36	0.08	0.2	-0.3	-0.6	-0.4	-0.72	-0.75	0.26	0.68	0.15		0.44	-0.64	0.45	-0.31	-0.41	-0.57	-0.78	0.15	-0.67	-0.67	-0.12	-0.49	-0.55	1.0
Current Deferred Revenue	-0.05	0.12	0.0	-0.3	-0.2	0.11	-0.28	-0.42	0.27	0.55	0.49	0.44		-0.4	0.5	-0.07	-0.13	-0.46	-0.41	0.45	-0.47	-0.06	0.18	-0.41	-0.12	0.44
Net Debt	-0.12	-0.62	-0.54	-0.27	0.49	0.35	0.92	0.94	-0.26	-0.38	-0.23	-0.64	-0.4		-0.4	-0.16	-0.03	0.85	0.95	-0.33	0.04	0.59	-0.3	0.88	-0.11	-0.64
Accounts Payable	0.29	0.42	0.26	-0.48	-0.49	0.08	-0.24	-0.44	0.51	0.79	0.45	0.45	0.5	-0.4		-0.13	0.21	-0.5	-0.45	0.44	-0.29	-0.07	0.46	-0.43	-0.51	0.45
Cash	0.68	0.58	0.47	0.49	-0.15	-0.19	0.14	0.19	-0.42	-0.1	0.09	-0.31	-0.07	-0.16	-0.13		0.59	-0.09	0.15	0.42	0.51	-0.07	0.49	0.09	0.51	-0.31
Non Current Assets Total	0.97	0.78	0.72	0.43	-0.39	-0.26	0.23	0.18	-0.2	-0.11	0.34	-0.41	-0.13	-0.03	0.21	0.59		-0.1	0.15	0.05	0.73	-0.07	0.83	0.11	0.39	-0.41
Non Currrent Assets Other	-0.18	-0.57	-0.44	-0.24	0.39	0.2	0.76	0.81	-0.29	-0.47	-0.42	-0.57	-0.46	0.85	-0.5	-0.09	-0.1		0.82	-0.33	0.05	0.46	-0.54	0.82	-0.08	-0.57
Long Term Debt	0.09	-0.44	-0.42	-0.09	0.5	0.34	0.97	0.99	-0.32	-0.44	-0.23	-0.78	-0.41	0.95	-0.45	0.15	0.15	0.82		-0.18	0.22	0.61	-0.14	0.89	0.1	-0.78
Cash And Short Term Investments	0.27	0.33	-0.06	-0.21	0.04	0.43	-0.1	-0.18	0.31	0.6	0.06	0.15	0.45	-0.33	0.44	0.42	0.05	-0.33	-0.18		-0.22	0.24	0.33	-0.34	-0.09	0.15
Net Receivables	0.68	0.51	0.49	0.74	0.05	-0.18	0.18	0.22	-0.27	-0.56	0.09	-0.67	-0.47	0.04	-0.29	0.51	0.73	0.05	0.22	-0.22		0.04	0.48	0.08	0.77	-0.67
Common Stock Total Equity	-0.05	-0.38	-0.71	-0.22	0.82	0.92	0.6	0.56	0.23	-0.2	-0.33	-0.67	-0.06	0.59	-0.07	-0.07	-0.07	0.46	0.61	0.24	0.04		-0.13	0.25	0.07	-0.67
Short Term Investments	0.86	0.81	0.64	0.33	-0.39	-0.14	-0.03	-0.13	0.06	0.24	0.55	-0.12	0.18	-0.3	0.46	0.49	0.83	-0.54	-0.14	0.33	0.48	-0.13		-0.22	0.27	-0.12
Non Current Liabilities Total	0.02	-0.45	-0.22	-0.15	0.16	-0.04	0.87	0.91	-0.42	-0.35	-0.15	-0.49	-0.41	0.88	-0.43	0.09	0.11	0.82	0.89	-0.34	0.08	0.25	-0.22		-0.11	-0.49
Other Current Assets	0.37	0.33	0.24	0.82	0.3	-0.04	-0.03	0.07	-0.24	-0.58	-0.03	-0.55	-0.12	-0.11	-0.51	0.51	0.39	-0.08	0.1	-0.09	0.77	0.07	0.27	-0.11		-0.55
Property Plant And Equipment Gross	-0.36	0.08	0.2	-0.3	-0.6	-0.4	-0.72	-0.75	0.26	0.68	0.15	1.0	0.44	-0.64	0.45	-0.31	-0.41	-0.57	-0.78	0.15	-0.67	-0.67	-0.12	-0.49	-0.55

Click cells to compare fundamentals

Innoviva Account Relationship Matchups

Innoviva fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	724.8M	999.6M	926.4M	1.2B	1.2B	1.3B
Total Stockholder Equity	313.5M	539.9M	414.7M	565.8M	675.0M	708.7M
Retained Earnings	(946.4M)	(722.0M)	(456.1M)	(204.9M)	(25.2M)	(26.4M)
Other Assets	293.6M	657.5M	425.2M	198.5M	228.2M	131.6M
Common Stock Shares Outstanding	113.4M	113.6M	94.3M	34.3M	36.1M	34.3M
Liabilities And Stockholders Equity	724.8M	999.6M	926.4M	1.2B	1.2B	1.3B
Other Stockholder Equity	1.3B	1.3B	870.2M	770.0M	699.5M	1.0B
Total Liab	382.7M	391.7M	400.5M	665.7M	568.6M	442.4M
Short Long Term Debt Total	377.1M	385.5M	394.7M	637.9M	449.1M	331.0M
Other Current Liab	5.4M	6.0M	5.8M	(63.8M)	28.9M	30.4M
Total Current Liabilities	5.4M	6.1M	5.8M	38.8M	38.1M	25.0M
Other Liab	586K	219K	106K	84.2M	75.8M	49.3M
Property Plant And Equipment Net	33K	28K	12K	3.4M	3.0M	2.9M
Net Debt	99.0M	139.0M	193.1M	346.8M	255.6M	192.9M
Accounts Payable	10K	66K	27K	2.9M	6.7M	7.1M
Cash	278.1M	246.5M	201.5M	291.0M	193.5M	138.1M
Non Current Assets Total	293.6M	657.5M	612.7M	788.0M	899.3M	944.3M
Non Currrent Assets Other	139.4M	214K	108K	101.9M	87.1M	68.4M
Long Term Debt	377.1M	385.5M	394.7M	540.4M	446.2M	321.7M
Cash And Short Term Investments	350.8M	246.5M	201.5M	291.0M	193.5M	235.5M
Net Receivables	79.4M	93.9M	110.7M	64.1M	84.1M	88.3M
Common Stock Total Equity	1.0M	1.0M	1.0M	696K	800.4K	857.6K
Short Term Investments	72.7M	438.3M	483.8M	403.0M	463.5M	486.6M
Non Current Liabilities Total	377.3M	385.6M	394.7M	626.9M	530.4M	426.9M
Other Current Assets	80.4M	95.6M	112.1M	32.5M	25.9M	28.2M
Property Plant And Equipment Gross	33K	28K	12K	3.4M	3.0M	2.9M
Total Current Assets	431.2M	342.1M	313.7M	443.5M	344.2M	281.5M
Common Stock	1.0M	1.0M	696K	692K	633K	845.9K
Property Plant Equipment	33K	28K	12K	3.4M	3.1M	2.9M
Inventory	(79.4M)	(93.9M)	(110.7M)	55.9M	40.7M	42.8M
Net Tangible Assets	313.5M	539.9M	414.7M	286.2M	329.1M	345.5M
Noncontrolling Interest In Consolidated Entity	152K	5.5M	67.9M	111.2M	127.9M	134.3M
Retained Earnings Total Equity	(1.5B)	(1.1B)	(722.0M)	(456.1M)	(524.6M)	(550.8M)
Long Term Debt Total	574.4M	382.9M	377.1M	385.5M	443.3M	463.7M
Capital Surpluse	1.3B	1.3B	1.3B	1.3B	1.1B	1.1B
Deferred Long Term Liab	139.1M	125.3M	111.4M	97.6M	112.2M	122.3M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Innoviva offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Innoviva's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Innoviva Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Innoviva Stock:

How To Invest In Innoviva

Details

Is Innoviva Stock a good investment?

Details

What is Innoviva's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Innoviva. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.

For information on how to trade Innoviva Stock refer to our How to Trade Innoviva Stock guide.

You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Complementary Tools for Innoviva Stock analysis

When running Innoviva's price analysis, check to measure Innoviva's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innoviva is operating at the current time. Most of Innoviva's value examination focuses on studying past and present price action to predict the probability of Innoviva's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innoviva's price. Additionally, you may evaluate how the addition of Innoviva to your portfolios can decrease your overall portfolio volatility.

	Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities
	Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market.
	Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
	Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities
	Global Correlations Find global opportunities by holding instruments from different markets

Is Innoviva's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Innoviva. If investors know Innoviva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Innoviva listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.65)

Earnings Share

2.2

Revenue Per Share

4.745

Quarterly Revenue Growth

0.305

Return On Assets

0.0712

The market value of Innoviva is measured differently than its book value, which is the value of Innoviva that is recorded on the company's balance sheet. Investors also form their own opinion of Innoviva's value that differs from its market value or its book value, called intrinsic value, which is Innoviva's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Innoviva's market value can be influenced by many factors that don't directly affect Innoviva's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Innoviva's value and its price as these two are different measures arrived at by different means. Investors typically determine if Innoviva is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Innoviva's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Innoviva Accounts Payable vs Treasury Stock Analysis

Accounts Payable vs Treasury Stock

Accounts Payable vs Treasury Stock Correlation Analysis

Correlation Coefficient

Accounts Payable

Treasury Stock

Innoviva fundamental ratios Correlations

Innoviva Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Innoviva fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Innoviva Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Long Term Debt	+ 0.99	Short Long Term Debt Total
Non Current Assets Total	+ 0.97	Total Assets
Short Long Term Debt Total	+ 0.97	Total Liab
Long Term Debt	+ 0.97	Total Liab
Long Term Debt	+ 0.95	Net Debt

Common Stock Shares Outstanding	- 0.82	Retained Earnings
Property Plant And Equipment Gross	- 0.78	Long Term Debt
Long Term Debt	- 0.78	Property Plant And Equipment Net
Other Stockholder Equity	- 0.77	Retained Earnings
Property Plant And Equipment Gross	- 0.75	Short Long Term Debt Total
Property Plant And Equipment Net	- 0.75	Short Long Term Debt Total